<DOC>
	<DOCNO>NCT02335086</DOCNO>
	<brief_summary>The purpose study : 1 . To examine association stable unstable coronary artery disease ( CAD ) marker DNA damage repair , 2 . To examine association plaque morphology assess frequency-domain optical coherence tomography ( FD-OCT ) marker DNA damage repair order identify potential marker plaque instability , 3 . To examine association marker DNA damage repair major adverse cardiovascular event define death , MI unplanned percutaneous surgical revascularization ,</brief_summary>
	<brief_title>DNA Damage &amp; Repair Proteins In Patients With Atherosclerotic Coronary Artery Disease</brief_title>
	<detailed_description>Hypotheses -- -- -- -- -- -- -- -- We hypothesise defective DNA damage response important aetiological factor development CAD , underlie CAD severity development . If hypothesis true , predict : 1 . There differential expression marker DNA damage repair patient stable angina , model stable CAD , patient non ST-elevation myocardial infarction ( NSTEMI ) , model unstable CAD . 2 . Differential expression marker DNA damage repair correlate plaque morphology stability define FD-OCT , 3 . Markers DNA damage repair serve distinguish marker stable unstable CAD , Methodology Study Population : Patients present stable angina undergo percutaneous revascularization Ashford St. Peter 's Hospitals Foundation Trust prospectively enrol . Data regard demographic , clinical , procedural characteristic patient collect Ashford St. Peter 's Hospitals Foundation Trust research personnel enter secure , encrypt , dedicated database . Pre-defined clinical angiographic inclusion exclusion criterion meet per DECODE study protocol . FD-OCT ( St. Jude Medical ILUMIEN OCT System ) perform three main epicardial coronary artery prior target vessel PCI administration glyceryl trinitrate . Data acquire designate , secure compute sent corelab analysis . Quantitative measurement include endoluminal area , plaque area , well plaque parameter include thin- cap fibroatheromas ( TCFA ) , fibrous tissue , lipid core calcium . TCFA define lipid-rich plaque cap thickness ≤ 65μm . Culprit lesion define accord electrocardiographic criterion ( ST-segment shift T-wave inversion ) angiographic appearance ( luminal irregularity consistent lesion ulceration , fill defect ( ) consistent thrombus , point angiographic maximal stenosis ) patient NSTEMI angiographic stenosis ≥ 70 % patient stable angina respond least two anti-anginal medication . Blood drawn immediately prior percutaneous coronary intervention . In addition routine haematological biochemical parameter ( complete blood count , white cell count , platelet count , creatinine , urea , sodium , potassium , cholesterol , glucose , troponine I , creatinine phosphokinase , liver function test clot screen ) one additional blood sample take separated plasma serum . Polymorphonuclear leukocyte use measurement DNA damage repair protein . Clinical follow-up occur 30-day 12-month enrolment telephone interview clinic visit . A repeat blood sample take analysis DNA damage repair protein . DNA Damage DNA damage analyse measure DNA strand break cell pellet use comet assay . Serum oxidise purine also measure use ELISA base assay . The transcriptional activation DNA damage protein assess real time PCR . For , RNA isolate use Roche High Pure Isolation kit . The RT2 First Strand Kit ( SABioscience ) utilise reverse transcription total RNA . Automated PCR set raw data normalise use average cycle threshold ( ct ) value four housekeeping gene ( B2M , RPL13A , GAPDH , ACTB ) . Whether differential gene expression lead differential protein expression determine Western blotting . Moreover , phosphorylation status DNA damage protein also assess . DNA repair activity also assess several DNA repair enzyme important repair base damage generate reactive oxygen nitrogen specie . DNA repair activity measure use in-vitro oligonucleotide-based cleavage assay . Finally , correlate measure DNA damage repair patient presentation ( stable angina vs. NSTEMI ) , MACE , FD-OCT derive parameter include number TCFA , plaque volume percentage plaque component . Statistical analysis Statistical analysis perform use SAS version 8.2 ( SAS institute Inc. , Cary , North Carolina ) . Biomarker parameter test association patient presentation ( stable angina vs. NSTEMI ) MACE use log-rank test . OCT derive parameter test association biomarkers use univariate Cox proportional hazard regression . Parameters significance level ≤0.1 univariate analysis undergo multivariate Cox proportional hazard analysis . A p value &lt; 0.05 consider statistically significant . The recruitment period anticipate last 15-18 month , data collation interpretation throughout recruitment analysis anticipate complete 24 month .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Atherosclerosis</mesh_term>
	<criteria>Inclusion Criteria Clinical : 1 . Age ≥ 18 year 2 . Stable angina respond least two antianginal medication ( beta blocker , calcium channel antagonist , long act nitrate , Nicorandil , Ivabradine , Ranolazine ) , NSTEMI . 3 . Patient able provide write , informed consent able follow protocol procedure . Angiographic : 1 . Successful uncomplicated percutaneous coronary intervention ( PCI ) perform major epicardial coronary artery . NB : Successful PCI define residual diameter stenosis &lt; 5 % treated lesion thrombolysis myocardial infarction ( TIMI ) 3 flow ( define normal flow fill distal coronary bed completely ) , absence intraprocedural chest pain STsegment change last &gt; 10 minute , persistent vessel closure , reflow , perforation , dissection requirement cardiopulmonary resuscitation , defibrillation , pacemaker intraaortic balloon implantation . Clinical : 1 . Presentation STelevation MI ( STEMI ) , 2 . Decompensated heart failure , hypotension , shock , refractory ventricular tachycardia , acute conduction disorder , leave ventricular ejection fraction ≤ 30 % , 3 . Prior coronary revascularization , 4 . Any form surgery three month prior enrolment , 5 . Active inflammatory disorder , 6 . Bleeding diathesis , 7 . Known allergy , hypersensitivity , contraindication aspirin , heparin , thienopyridines , 8 . Life expectancy less 1 year , 9 . Diabetes mellitus . Angiographic : 1 . Left main coronary artery stenosis ≥ 50 % , 2 . Coronary artery bypass surgery plan within one year PCI , 3 . Anatomical condition preclude threevessel FDOCT ( significant tortuosity , severe calcification , chronic total occlusion ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>